Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
September 15, 2026 Drug delivery / Pharma applications

HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms

This study developed a new vaginal hydrogel to treat genitourinary syndrome of menopause, aiming to improve drug retention and patient

Continue reading

September 14, 2026 CD as API / Pharma applications

Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis

Purpose: Although sugammadex may promote earlier postoperative mobilization and transiently affect coagulation parameters, its association with the risk of venous

Continue reading

September 11, 2026 CD derivatives / Non-pharma applications / Pharma applications

Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”

The Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition” will be published in the International Journal of Molecular Sciences

Continue reading

July 25, 2018 CD as API / Events / Pharma applications

Annual National Niemann Pick Disease Foundation Conference

Among several lectures useful for the families with member(s) suffering in rare diseases the ongoing clinical trials for NPC patients

Continue reading

Posts pagination

«Previous Posts 1 … 205 206 207

Recent Posts

  • HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (356)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (817)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,221)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • MANU-KAMU - Dog dental treats with cyclodextrin
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Beyond Cholesterol: New Review Examines 7-Ketocholesterol and Its Role in Disease
  • Synthesis and potential applications of cyclodextrin-based metal–organic frameworks: a review
  • Piroxicam/Cyclodextrin: 35 years on the market
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...